Markus Hildner
Impact in
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- T-cell and B-cell Immunology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 5
-
- Atherosclerosis and Cardiovascular Diseases 5
- Immunotherapy and Immune Responses 2
- Co-authors
- Andreas J. R. Habenicht (10 shared papers)Rainer Spanbroek (6 shared papers)Katharina Lötzer (5 shared papers)Olof Rådmark (3 shared papers)Bengt O. Samuelsson (3 shared papers)Hartmut Kühn (2 shared papers)Anja Urbach (2 shared papers)Rolf Gräbner (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Blood (1 paper)Carcinogenesis (1 paper)Nature Medicine (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Markus Hildner
15 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 78
- Biochemistry 281
- Immunology 599
- Pharmacology 237
- Neurology 85
- Physiology 176
Countries citing papers authored by Markus Hildner
This map shows the geographic impact of Markus Hildner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hildner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hildner more than expected).
Fields of papers citing papers by Markus Hildner
This network shows the impact of papers produced by Markus Hildner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hildner. The network helps show where Markus Hildner may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hildner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 395 | |
| 2 | 2009 | 340 | |
| 3 | 2019 | 236 | |
| 4 | 2001 | 94 | |
| 5 | 2003 | 92 | |
| 6 | 2010 | 92 | |
| 7 | 2006 | 81 | |
| 8 | 1998 | 54 | |
| 9 | 2000 | 52 | |
| 10 | 2014 | 36 | |
| 11 | 2011 | 22 | |
| 12 | 2011 | 20 | |
| 13 | 2019 | 17 | |
| 14 | 2007 | 9 | |
| 15 | 2022 | 4 |
About Markus Hildner
Markus Hildner is a scholar working on Biochemistry, Immunology, Pharmacology, Neurology and Dermatology, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Barrier Structure and Function Studies (2 papers), Immunotherapy and Immune Responses (2 papers), Dermatology and Skin Diseases (1 paper), Cervical Cancer and HPV Research (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Biochemistry (281 citations), Immunology (599 citations), Pharmacology (237 citations), Neurology (85 citations) and Physiology (176 citations). Markus Hildner has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Andreas J. R. Habenicht, Rainer Spanbroek, Katharina Lötzer, Olof Rådmark, Bengt O. Samuelsson, Hartmut Kühn, Anja Urbach, Rolf Gräbner, Gabriele A.M. Plenz and Katharina Rühling. Their work appears in journals such as Proceedings of the National Academy of Sciences, Arteriosclerosis Thrombosis and Vascular Biology, Blood, Carcinogenesis and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.